Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
143,3 USD | -0,28% | -0,76% | -25,13% |
08/04 | Sectorupdate: Gezondheidszorgaandelen maandag vlak tot hoger premarket | MT |
08/04 | Sectorupdate: Gezondheidszorg | MT |
Omzet 2024 * | 1,85 mld. 1,73 mld. | Omzet 2025 * | 2,27 mld. 2,12 mld. | Marktkapitalisatie | 18,12 mld. 16,95 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -515 mln. -482 mln. | Nettowinst (verlies) 2025 * | -243 mln. -227 mln. | EV/omzet 2024 * | 9,6 x |
Nettoliquiditeiten 2024 * | 340 mln. 318 mln. | Nettoliquiditeiten 2025 * | 599 mln. 560 mln. | EV/omzet 2025 * | 7,72 x |
K/w-verhouding 2024 * |
-35
x | K/w-verhouding 2025 * |
-81,8
x | Werknemers | 2.100 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,59% |
Recentste transcriptie over Alnylam Pharmaceuticals, Inc.
1 dag | -0,28% | ||
1 week | -0,76% | ||
Lopende maand | -4,11% | ||
1 maand | -5,70% | ||
3 maanden | -20,21% | ||
6 maanden | -7,93% | ||
Lopend jaar | -25,13% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 61 | 19-09-16 | |
Jeffrey Poulton
DFI | Director of Finance/CFO | 56 | 13-08-19 |
Piyush Sharma
CMP | Compliance Officer | - | 21-09-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Pyott
BRD | Director/Board Member | 70 | 18-12-15 |
Charles Sigal
BRD | Director/Board Member | 72 | 22-08-22 |
Margaret Hamburg
BRD | Director/Board Member | 68 | 10-01-19 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
5.08% | 1 M€ | 0,00% | - | |
4.04% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 143,3 | -0,28% | 479 139 |
25-04-24 | 143,7 | -0,06% | 489 265 |
24-04-24 | 143,8 | -1,55% | 395 369 |
23-04-24 | 146,1 | +0,19% | 543 726 |
22-04-24 | 145,8 | +0,96% | 399 984 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-25,13% | 18,12 mld. | |
+1,51% | 42,75 mld. | |
+8,57% | 41,34 mld. | |
+49,22% | 41,61 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. | |
-16,98% | 10,07 mld. |